Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
This once-daily, single-tablet antiretroviral regimen combines an integrase strand transfer inhibitor with two nucleos(t)ide reverse transcriptase inhibitors to provide effective management of HIV-1 infection, in alignment with WHO and NACO treatment guidelines.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (Bictegravir)
Nucleos(t)ide Reverse Transcriptase Inhibitors (Emtricitabine + Tenofovir Alafenamide)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of an ART regimen in line with treatment guidelines.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
30 Tablets
Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
This once-daily, single-tablet antiretroviral regimen combines an integrase strand transfer inhibitor with two nucleos(t)ide reverse transcriptase inhibitors to provide effective management of HIV-1 infection, in alignment with WHO and NACO treatment guidelines.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (Bictegravir)
Nucleos(t)ide Reverse Transcriptase Inhibitors (Emtricitabine + Tenofovir Alafenamide)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of an ART regimen in line with treatment guidelines.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
30 Tablets
Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg
This once-daily, single-tablet antiretroviral regimen combines an integrase strand transfer inhibitor with two nucleos(t)ide reverse transcriptase inhibitors to provide effective management of HIV-1 infection, in alignment with WHO and NACO treatment guidelines.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (Bictegravir)
Nucleos(t)ide Reverse Transcriptase Inhibitors (Emtricitabine + Tenofovir Alafenamide)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of an ART regimen in line with treatment guidelines.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
30 Tablets